3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
4
Head & Neck
2
Gynecologic
2
Thoracic
1
NET
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Conditions
Neuroendocrine Tumors
25
Pituitary Neoplasms
10
Pheochromocytoma
10
Carcinoma, Neuroendocrine
9
Thyroid Neoplasms
8
Sarcoma
8
Thyroid Cancer, Papillary
6
Paraganglioma
5
Ovarian Neoplasms
5
Neuroblastoma
5
Adrenocortical Carcinoma
5
Small Cell Lung Carcinoma
4
Parathyroid Neoplasms
4
Pancreatic Neoplasms
4
Osteosarcoma
4
Neoplasms
4
Carcinoma, Renal Cell
4
Carcinoma, Non-Small-Cell Lung
4
Carcinoma, Medullary
4
Adrenal Gland Neoplasms
4
Thyroid Carcinoma, Anaplastic
3
Stomach Neoplasms
3
Prostatic Neoplasms
3
Pituitary ACTH Hypersecretion
3
Melanoma
3
Head and Neck Neoplasms
3
Cushing Syndrome
3
Colorectal Neoplasms
3
Cholangiocarcinoma
3
Carcinoma, Hepatocellular
3
Interventions
olaparib
1
lutetium Lu 177 dotatate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma, Synovial
×
Endocrine
×
30 days
×
Clear all
NCT06607692
2026-06-04
LUPARPED
Fundación de investigación HM
Phase 1/2
Recruiting
25 enrolled